NASDAQ:SWTX
SpringWorks Therapeutics, Inc. Stock News
$41.46
-1.15 (-2.70%)
At Close: May 31, 2024
SpringWorks Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
06:30am, Tuesday, 05'th Jan 2021
STAMFORD, Conn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients
SpringWorks Therapeutics Announces Executive Leadership Promotions
09:00am, Tuesday, 15'th Dec 2020
STAMFORD, Conn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients